vTv Therapeutics Inc. Archives

Investments Worthy Stock: vTv Therapeutics Inc. (NASDAQ:VTVT), Progress Software Corporation (NASDAQ:PRGS), The Goldman Sachs Group, Inc. (NYSE:GS), The Bank of New York Mellon Corporation (NYSE:BK)

June 28, 2019June 28, 2019

vTv Therapeutics Inc. (NASDAQ:VTVT) initiated its Phase 2 clinical trial for evaluating azeliragon in patients with mild Alzheimer’s disease and Type 2 Diabetes. vTv Therapeutics …

Markets

Insider Buying: vTv Therapeutics Inc. (NASDAQ:VTVT)

June 26, 2019June 26, 2019

vTv Therapeutics Inc. (NASDAQ:VTVT) major shareholder Ronald O. Perelman purchased 1,358,698 shares of the business’s stock in a transaction on Wednesday, May 15th. The stock …